cjc1295 without dac ipamorelin CJC-1295 (5mg) / (5mg) Buy CJC-1295 No DAC +

Results may vary depending on individual health status and treatment frequency

WO 2015/161276, the disclosure of which is hereby incorporated by reference and described herein below

Developed by Novo Nordisk in the late 1990s, ipamorelin stimulates growth hormone (GH) release from somatotroph cells in the anterior pituitary gland through direct receptor activation, triggering the Gq/11-phospholipase C signalling cascade that leads to calcium-mediated exocytosis of GH-containing secretory granules

Due to the modulation of redox mechanisms in obesity, evidence suggests that a multimodal approach to treatment including diet changes, exercise, and medical treatments may be successful in curbing oxidant stress (Thompson et al., 2007

Elife 6:e25460

At Perfect B in Doral, FL, CJC-1295/Ipamorelin is part of a clinical evaluation that begins with baseline labs, includes provider review of hormonal status, and is adjusted based on your response data throughout the protocol